Target Name: TBX15
NCBI ID: G6913
Review Report on TBX15 Target / Biomarker Content of Review Report on TBX15 Target / Biomarker
TBX15
Other Name(s): T-box protein 14 | T-box transcription factor TBX15 | T-box transcription factor TBX15 (isoform 2) | T-box transcription factor 15, transcript variant 2 | TBX14 | TBX15 variant 2 | T-box 15 | T-box transcription factor TBX14 | TBX15_HUMAN | T-box 14 | T-box transcription factor 15 | T-box protein 15

TBX15: A Protein Targeted for Cancer and Other Diseases

TBX15, also known as T-box protein 15, is a protein that is expressed in a variety of tissues throughout the body. It is a key regulator of cell proliferation and has been implicated in the development and progression of many diseases, including cancer. In recent years, researchers have been investigating TBX15 as a potential drug target or biomarker, with the hope of using it to treat a variety of diseases.

TBX15 is a transmembrane protein that is involved in the T-box gene family. This family of proteins plays a critical role in regulating gene expression and is thought to be involved in the development and progression of many diseases. TBX15 is a 21-kDa protein that is expressed in a variety of tissues, including muscle, nerve, and heart. It is highly conserved, with a calculated pI of 1.17 and a predicted localization in the cell membrane as a protein that is involved in intracellular signaling.

One of the key functions of TBX15 is its role in cell proliferation. It is a negative regulator of the cyclin D1 gene, which encodes the cyclin D1 protein. This means that when TBX15 is activated, it works to inhibit the activity of the cyclin D1 protein, which is necessary for cell proliferation. This mechanism of regulation is important because it helps to prevent the rapid growth and division that can occur in cancer cells.

In addition to its role in cell proliferation, TBX15 is also involved in the regulation of cell survival. It has been shown to play a role in the regulation of cell apoptosis, which is the process by which cells undergo programmed cell death. This is important because the regulation of cell apoptosis is critical for the development of many diseases, including cancer.

TBX15 has also been shown to be involved in the regulation of cellular signaling pathways. It is a signaling molecule that can interact with a variety of intracellular proteins, including tyrosine kinases. This interaction between TBX15 and these proteins allows it to regulate cellular signaling pathways and contribute to the development of many diseases.

As a potential drug target, TBX15 has the potential to be used to treat a variety of diseases. For example, it has been shown to be involved in the regulation of cancer cell growth and has been shown to interact with several proteins that are associated with cancer. This suggests that TBX15 could be a useful target for cancer therapies. In addition, TBX15 has also been shown to be involved in the regulation of cellular signaling pathways and could potentially be used to treat a variety of other diseases.

In conclusion, TBX15 is a protein that is expressed in a variety of tissues throughout the body and is involved in the regulation of cell proliferation and survival. It has also been shown to play a role in the regulation of cellular signaling pathways and has the potential to be used to treat a variety of diseases. Further research is needed to fully understand the role of TBX15 in disease and to develop effective therapies based on it.

Protein Name: T-box Transcription Factor 15

Functions: Probable transcriptional regulator involved in the development of the skeleton of the limb, vertebral column and head. Acts by controlling the number of mesenchymal precursor cells and chondrocytes (By similarity)

The "TBX15 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about TBX15 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

TBX18 | TBX18-AS1 | TBX19 | TBX2 | TBX20 | TBX21 | TBX22 | TBX3 | TBX4 | TBX5 | TBX5-AS1 | TBX6 | TBXA2R | TBXAS1 | TBXT | TC2N | TCAF1 | TCAF1P1 | TCAF2 | TCAIM | TCAM1P | TCAP | TCEA1 | TCEA1P2 | TCEA2 | TCEA3 | TCEAL1 | TCEAL2 | TCEAL3 | TCEAL4 | TCEAL5 | TCEAL6 | TCEAL7 | TCEAL8 | TCEAL9 | TCEANC | TCEANC2 | TCERG1 | TCERG1L | TCF12 | TCF12-DT | TCF15 | TCF19 | TCF20 | TCF21 | TCF23 | TCF24 | TCF25 | TCF3 | TCF4 | TCF7 | TCF7L1 | TCF7L2 | TCFL5 | TCHH | TCHHL1 | TCHP | TCIM | TCIRG1 | TCL1A | TCL1B | TCL6 | TCN1 | TCN2 | TCOF1 | TCP1 | TCP10L | TCP10L2 | TCP10L3 | TCP11 | TCP11L1 | TCP11L2 | TCP11X2 | TCTA | TCTE1 | TCTN1 | TCTN2 | TCTN3 | TDG | TDGF1 | TDGF1P3 | TDGP1 | TDH | TDH-AS1 | TDO2 | TDP1 | TDP2 | TDRD1 | TDRD10 | TDRD12 | TDRD15 | TDRD3 | TDRD5 | TDRD6 | TDRD7 | TDRD9 | TDRG1 | TDRKH | TDRKH-AS1 | TDRP